Who owns TRAWS PHARMA INC?
- Ticker: TRAW
- CUSIP Number: 68232v884
Tip: Access positions for across all investors
Analyze quarterly positions in Traws Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Traws Pharma stock
Who bought or sold TRAWS PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 606k | $1.1M | 0% | Sep 2025 |
|
| Adage Capital Partners GP | 330k | $611k | 0% | Sep 2025 |
|
| Vestal Point Capital | 150k | $278k | 0% | Sep 2025 |
|
| Vanguard Group | 87k | $162k | 562% | Sep 2025 |
|
| Geode Capital Management | 43k | $80k | 22% | Sep 2025 |
|
| Ikarian Capital | 29k | $53k | 0% | Sep 2025 |
|
| Two Sigma Investments | 22k | $41k | 37% | Sep 2025 |
|
| Hrt Financial | 13k | $23k | 100% | Sep 2025 |
|
| XTX Topco | 11k | $20k | 100% | Sep 2025 |
|
| BlackRock | 10k | $18k | 0% | Sep 2025 |
|
| Morgan Stanley | 719.00 | $1.1k | 100% | Jun 2025 |
|
| SBI Securities | 162.00 | $300.007800 | 0% | Sep 2025 |
|
| Vermillion & White Wealth Management Group | 96.00 | $178.003200 | 0% | Sep 2025 |
|
| UBS Group | 6.00 | $10.999800 | -100% | Sep 2025 |
|
| Assetmark | 2.00 | $4.000000 | 100% | Sep 2025 |
|
| FMR | 2.00 | $4.000000 | 0% | Sep 2025 |
|
Who sold out of Traws Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alyeska Investment Group | Jun 2025 | 53k | $78k |
| Two Sigma Securities | Jun 2025 | 17k | $25k |
| Tower Research Capital | Jun 2025 | 706.00 | $1.0k |
| Raymond James Financial | Jun 2025 | 102.00 | $151.000800 |